Acceder

Farmas USA

136K respuestas
Farmas USA
85 suscriptores
Farmas USA
Página
15.588 / 17.019
#124697

Re: Farmas USA

ZSAN al hoyo un 50%
$ZSAN received a discipline review letter (“DRL”) from the U.S. Food and Drug Administration (“FDA”) in connection with the Qtrypta™ (zolmitriptan transdermal microneedle system) 505(b)(2) New Drug Application (“NDA”).
#124698

Re: Farmas USA

$SRNE Sorrento Therapeutics S-3 Files To Sell $1.83M Shares Of Common Stock For Holders